Tucson, AZ, United States of America

Dana Swenson

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dana Swenson in Filovirus Research

Introduction

Dana Swenson is a notable inventor based in Tucson, Arizona. With a focus on virology, she has made significant strides in understanding filoviruses, particularly through her pioneering research on virus-like particles.

Latest Patents

Dana Swenson holds a patent titled "Generation of Virus-Like Particles and Use as Panfilovirus Vaccine." This groundbreaking patent describes filovirus-like particles for both Ebola and Marburg viruses. It details their application as diagnostic and therapeutic agents, as well as their potential use in developing a filovirus vaccine. The patent also covers the important association of Ebola and Marburg with lipid rafts during the assembly and budding processes, highlighting the necessity of functional rafts for the entry of filoviruses into host cells.

Career Highlights

Dana is employed by the United States of America as Represented by the Secretary of the Army, where she applies her expertise in virology to contribute to public health and safety. Her innovative approach to vaccine development has positioned her as a key player in the field of infectious disease research.

Collaborations

Throughout her career, Dana Swenson has collaborated with esteemed colleagues, including Sina Bavari and M. Javad Aman. These partnerships have further enhanced her research capabilities and expanded the reach of her innovations within the scientific community.

Conclusion

Dana Swenson's contributions to the field of virology, particularly through her patent on virus-like particles, showcase her dedication to advancing medical science. Her efforts not only provide pivotal insights into filovirus behavior but also open pathways for future therapeutic developments. As research continues, innovators like Dana will remain at the forefront of efforts to combat viral diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…